Needham & Company Downgrades NPS Pharmaceuticals Inc. (NPSP) to Hold on Buyout
Tweet Send to a Friend
Needham & Company downgraded NPS Pharmaceuticals Inc. (NASDAQ: NPSP) from Buy to Hold.Analyst Alan Carr commented, "Shire announced on 1/11/15 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
